Taktile, a leading provider of decision automation software for banks and fintechs, announced today that it has been recognized as a member of the World Economic Forum’s Global Innovators Community—an invitation-only group of the world’s most promising technology leaders. This recognition underscores Taktile’s role as a pioneer in AI-driven software for financial institutions and its commitment to shaping inclusive, resilient, and sustainable systems. Taktile’s platform empowers risk function...

Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standard-of-care to cure cancer and infectious diseases, today unveiled its upcoming contributions to the 2025 Annual American Society of Clinical Oncology (ASCO) Meeting in Chicago, Illinois. The contributions feature three clinical poster presentations and one translational research abstract publication, highlighting Debio 0123’s potential across solid tumors. Among them ...